STTK Shattuck Labs, Inc.
$5.77▲ +4.15%
Healthcare
Other
After hours
$5.77▲ +0.00%
Oct 27, 4:01 PM ET
Volume 699.5K
Avg Volume (10D) 1.05M
Key Metrics & Fundamentals
Market Cap
$579.10M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.72 - 8.33
% vs 50 MA
-9.70%
% vs 200 MA
-4.14%
RSI-14
47.2
MACD Histogram
+0.0300
Beta (1Y vs SPY)
0.98
Free Cash Flow
-$10.33M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$15.30M
COGS
–
Operating Exp
$16.16M
Operating Income
-$16.16M
EBIT
-$16.16M
Pretax Income
-$15.15M
Net Income
-$15.15M
EPS (Diluted)
-0.12
Price & Volume History
Loading chart…
Recent News
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
GlobeNewswire · Oct 13, 2026 8:00 AM ET
UBS Initiates Shattuck Labs at Buy With $17 Price Target
MT Newswires · Oct 12, 2026 7:44 AM ET
Update: Wedbush Lifts Price Target on Shattuck Labs to $14 From $11, Keeps Outperform Rating
MT Newswires · Oct 1, 2026 12:05 PM ET
Wedbush Lifts Price Target on Shattuck Labs to $14 From $11, Keeps Outperform Rating
MT Newswires · Oct 1, 2026 9:25 AM ET
Shattuck Labs Plans Phase 2 Trial of Chronic Inflammatory Skin Disease Drug
MT Newswires · Oct 1, 2026 7:58 AM ET
Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development
GlobeNewswire · Oct 1, 2026 7:00 AM ET
Hut 8 Insider Sold Shares Worth $2,000,000, According to a Recent SEC Filing
MT Newswires · Sep 29, 2026 3:34 AM ET
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
GlobeNewswire · Sep 2, 2026 4:05 PM ET
What Shattuck Labs Stock Topped the Market on Monday
Motley Fool · Aug 24, 2026 6:23 PM ET
Raymond James Initiates Coverage on Shattuck Labs With Strong Buy Rating, $18 Price Target
MT Newswires · Aug 24, 2026 7:39 AM ET
Financial Overview - Income Statement
Quarterly
Sep 2025
See STTK's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.